{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:42:55Z","timestamp":1782603775834,"version":"3.54.5"},"reference-count":29,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,21]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>The risk of transformation of NLPHL to DLBCL is 0.74 per 100 patient-years of follow-up. Risk factors for transformation include prior exposure to chemotherapy and splenic involvement at time of diagnosis.<\/jats:p>","DOI":"10.1182\/blood-2015-08-665505","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T22:59:04Z","timestamp":1454453944000},"page":"1960-1966","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":60,"title":["Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution"],"prefix":"10.1182","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2767-3830","authenticated-orcid":false,"given":"Saad Sirop","family":"Kenderian","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Macon","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay M.","family":"Ristow","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Colgan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Inwards","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetomir N.","family":"Markovic","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana N.","family":"Micallef","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Porrata","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Martenson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz S.","family":"Nowakowski","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111902283163500_B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"19","key":"2019111902283163500_B2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111902283163500_B3","first-page":"19","article-title":"[Hodgkin disease with nodular lymphocytic predominance or type I (paragranuloma of Poppema-Lennert): a clinico-pathological entity. Study of 21 cases and review of the literature].","volume":"20","author":"Meignin","year":"2000","journal-title":"Ann Pathol"},{"issue":"3","key":"2019111902283163500_B4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00390466","article-title":"Clinical features of nodular paragranuloma (Hodgkin\u2019s disease, lymphocyte predominance type, nodular).","volume":"108","author":"Hansmann","year":"1984","journal-title":"J Cancer Res Clin Oncol"},{"key":"2019111902283163500_B5","author":"Russell"},{"issue":"66","key":"2019111902283163500_B6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0609.2005.00462.x","article-title":"Lymphocyte-predominant and classical Hodgkin\u2019s lymphoma--comparison of outcomes.","author":"Nogov\u00e1","year":"2005","journal-title":"Eur J Haematol Suppl"},{"issue":"9","key":"2019111902283163500_B7","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1200\/JCO.1997.15.9.3060","article-title":"Clinical presentation and outcome in lymphocyte-predominant Hodgkin\u2019s disease.","volume":"15","author":"Bodis","year":"1997","journal-title":"J Clin Oncol"},{"issue":"26","key":"2019111902283163500_B8","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"key":"2019111902283163500_B9","author":"Bennett"},{"issue":"12","key":"2019111902283163500_B10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19830615)51:12<2293::AID-CNCR2820511221>3.0.CO;2-X","article-title":"Hodgkin\u2019s disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin\u2019s lymphomas.","volume":"51","author":"Miettinen","year":"1983","journal-title":"Cancer"},{"issue":"8","key":"2019111902283163500_B11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/1042819031000149421","article-title":"Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group.","volume":"45","author":"Huang","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2019111902283163500_B12","first-page":"599","article-title":"Lymphocyte predominant Hodgkin\u2019s disease nodular subtype with coexistent \u201clarge cell lymphoma\u201d. Histological progression or composite malignancy?","volume":"12","author":"Sundeen","year":"1988","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2019111902283163500_B13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group.","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer"},{"key":"2019111902283163500_B14","author":"Jackson"},{"issue":"6","key":"2019111902283163500_B15","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1002\/ajh.23989","article-title":"Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience.","volume":"90","author":"Eyre","year":"2015","journal-title":"Am J Hematol"},{"key":"2019111902283163500_B16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1471-2407-14-332","article-title":"Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology.","volume":"14","author":"Hartmann","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"2019111902283163500_B17","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1182\/blood.V86.6.2312.bloodjournal8662312","article-title":"Clonal relationship between lymphocytic predominance Hodgkin\u2019s disease and concurrent or subsequent large-cell lymphoma of B lineage.","volume":"86","author":"Wickert","year":"1995","journal-title":"Blood"},{"issue":"2","key":"2019111902283163500_B18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V88.2.657.bloodjournal882657","article-title":"Nodular lymphocyte-predominant Hodgkin\u2019s disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction.","volume":"88","author":"Greiner","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2019111902283163500_B19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1309\/KY8C-LCYN-QHJ6-4C6R","article-title":"The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis.","volume":"116","author":"Ohno","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2019111902283163500_B20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","article-title":"Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin\u2019s lymphoma.","volume":"28","author":"Al-Mansour","year":"2010","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019111902283163500_B21","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111902283163500_B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1987.5.1.27","article-title":"Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin\u2019s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.","volume":"5","author":"Santoro","year":"1987","journal-title":"J Clin Oncol"},{"issue":"14","key":"2019111902283163500_B23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111902283163500_B24","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3109\/10428194.2011.584993","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.","volume":"52","author":"Farrell","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"32","key":"2019111902283163500_B25","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma.","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J Clin Oncol"},{"key":"2019111902283163500_B26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunohistochemistry era: a report from the University of Iowa\/Mayo Clinic SPORE molecular epidemiology resource.","author":"Link","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111902283163500_B27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.leukres.2004.09.008","article-title":"Richter\u2019s transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.","volume":"29","author":"Thornton","year":"2005","journal-title":"Leuk Res"},{"issue":"6","key":"2019111902283163500_B28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjh.12458","article-title":"Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.","volume":"162","author":"Parikh","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111902283163500_B29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2009.24.0945","article-title":"Early-stage, lymphocyte-predominant Hodgkin\u2019s lymphoma: patient outcomes from a large, single-institution series with long follow-up.","volume":"28","author":"Chen","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/16\/1960\/1392818\/1960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/16\/1960\/1392818\/1960.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:28:57Z","timestamp":1574130537000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/16\/1960\/34842\/Large-Bcell-transformation-in-nodular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":29,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,4,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-08-665505","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}